Trial of Atheroma Regression Evaluated with Integrated Backscatter Intravascular Ultrasound by administering Sitagliptin.

Trial Profile

Trial of Atheroma Regression Evaluated with Integrated Backscatter Intravascular Ultrasound by administering Sitagliptin.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2016

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms TRUST
  • Most Recent Events

    • 25 Jul 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 05 Feb 2013 Actual initiation date changed from Mar 2012 to Feb 2012 as reported by University Hospital Medical Information Network - Japan record.
    • 05 Feb 2013 Planned End Date changed from 28 Feb 2014 to 31 Jan 2015 as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top